Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Market Cap
$738.45M
EBITDA Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$726.75M
EBITDA Margin
-27116.80%
TTM Avg
-23848.80%
3Y Avg
-16467.00%
5Y Avg
-16467.00%
Market Cap
$723.48M
EBITDA Margin
-414.93%
TTM Avg
-258.43%
3Y Avg
-185.54%
5Y Avg
-212.52%
Market Cap
$711.21M
EBITDA Margin
-123018.64%
TTM Avg
-69257.96%
3Y Avg
-35033.94%
5Y Avg
-23599.85%
Market Cap
$764.31M
EBITDA Margin
16.77%
TTM Avg
16.87%
3Y Avg
-15.22%
5Y Avg
-3.72%
Market Cap
$765.29M
EBITDA Margin
-4915.19%
TTM Avg
-4915.19%
3Y Avg
-4915.19%
5Y Avg
-4915.19%
Market Cap
$709.36M
EBITDA Margin
52.93%
TTM Avg
53.31%
3Y Avg
49.89%
5Y Avg
44.80%
Market Cap
$704.20M
EBITDA Margin
-14.10%
TTM Avg
-9.55%
3Y Avg
-6.60%
5Y Avg
-0.48%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apnimed, Inc. (APMD) | $737.53M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $738.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| Candel Therapeutics, Inc. (CADL)vs › | $726.75M | -27116.80% | -23848.80% | -16467.00% | -16467.00% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $723.48M | -414.93% | -258.43% | -185.54% | -212.52% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $711.21M | -123018.64% | -69257.96% | -35033.94% | -23599.85% |
| Mesa Laboratories, Inc. (MLAB)vs › | $764.31M | 16.77% | 16.87% | -15.22% | -3.72% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $765.29M | -4915.19% | -4915.19% | -4915.19% | -4915.19% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.36M | 52.93% | 53.31% | 49.89% | 44.80% |
| Cytek Biosciences, Inc. (CTKB)vs › | $704.20M | -14.10% | -9.55% | -6.60% | -0.48% |
| Sana Biotechnology, Inc. (SANA)vs › | $775.04M | N/A | N/A | N/A | N/A |
Gross Margin
N/A
EBITDA Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
